We use cookies to improve your experience. By continuing to browse this site, you accept our cookie policy.×
Skip main navigation
Aging Health
Bioelectronics in Medicine
Biomarkers in Medicine
Breast Cancer Management
CNS Oncology
Colorectal Cancer
Concussion
Epigenomics
Future Cardiology
Future Medicine AI
Future Microbiology
Future Neurology
Future Oncology
Future Rare Diseases
Future Virology
Hepatic Oncology
HIV Therapy
Immunotherapy
International Journal of Endocrine Oncology
International Journal of Hematologic Oncology
Journal of 3D Printing in Medicine
Lung Cancer Management
Melanoma Management
Nanomedicine
Neurodegenerative Disease Management
Pain Management
Pediatric Health
Personalized Medicine
Pharmacogenomics
Regenerative Medicine

Development of a multiplex real-time RT-PCR assay for detection of human parainfluenza viruses in patients with respiratory symptoms

    Mahboobeh Ramezannia

    Department of Influenza & Other Respiratory Viruses, Pasteur Institute of Iran, Tehran, Iran

    Department of Microbiology, Faculty of Biological Sciences, Shahid Beheshti University, Tehran, Iran

    ,
    Seyed Masoud Hosseini

    Department of Microbiology, Faculty of Biological Sciences, Shahid Beheshti University, Tehran, Iran

    ,
    Fatemeh Fotouhi

    *Author for correspondence:

    E-mail Address: fotouhi@pasteur.ac.ir

    Department of Influenza & Other Respiratory Viruses, Pasteur Institute of Iran, Tehran, Iran

    ,
    Behzad Khansarinejad

    Department of Microbiology & Immunology, Arak University of Medical Sciences, Arak, Iran

    &
    Vahideh Mazaheri

    Department of Influenza & Other Respiratory Viruses, Pasteur Institute of Iran, Tehran, Iran

    Published Online:https://doi.org/10.2217/fvl-2016-0052

    Aim: The human parainfluenza viruses (HPIVs) are common viral causes of both upper and lower respiratory tract infections in infants and children. The purpose of this study was to develop a real-time reverse transcription PCR assay to detect HPIVs in clinical specimens in a single test. Specimens: Specific primers and probes matched to conserved region of hemagglutinin–neuraminidase genes were designed. Clinical specimens were collected from hospitalized children of ≤5 years old. Results & conclusion: Of 230 specimens, 48 samples contained one of HPIV types 1–4. The most percentage of positive HPIVs belonged to HPIV2. HPIVs were found in fall, winter and spring but not in summer months. In conclusion, our in-house multiplex real-time reverse transcription PCR is a suitable technique for simultaneous detection of HPIVs in clinical samples.

    Papers of special note have been highlighted as: •• of considerable interest

    References

    • 1 Taibleson MH. Fourier Analysis on Local Fields (MN-15). Griffiths PA, Mather JN, Stein EM (eds). Princeton University Press, Princeton, NJ, USA, 15 (2015).
    • 2 Henrickson KJ. Parainfluenza viruses. Clin. Microbiol. Rev. 16(2), 242–264 (2003). •• Used due to its general information about the basic structures, epidemiology, clinical features and laboratory diagnosis of human parainfluenza viruses.
    • 3 Templeton KE, Scheltinga SA, Beersma MFC, Kroes ACM, Claas ECJ. Rapid and sensitive method using multiplex real-time PCR for diagnosis of infections by influenza A and influenza B viruses, respiratory syncytial virus, and parainfluenza viruses 1, 2, 3, and 4. J. Clin. Microbiol. 42(4), 1564–1569 (2004). •• Chosen because of its details of respiratory samples, primer and probe design, and RNA extraction, primarily set up by conventional PCR and real-time PCR and the evaluation of specificity and sensitivity of this assay.
    • 4 Van De Pol AC, Van Loon AM, Wolfs TFW et al. Increased detection of respiratory syncytial virus, influenza viruses, parainfluenza viruses, and adenoviruses with real-time PCR in samples from patients with respiratory symptoms. J. Clin. Microbiol. 45(7), 2260–2262 (2007).
    • 5 Vainionpää R, Hyypiä T. Biology of parainfluenza viruses. Clin. Microbiol. Rev. 7(2), 265–275 (1994).
    • 6 Frank AL, Couch R, Griffis C, Baxter B. Comparison of different tissue cultures for isolation and quantitation of influenza and parainfluenza viruses. J. Clin. Microbiol. 10(1), 32–36 (1979).
    • 7 Van Woensel J, Van Aaldersen W, Kimpen J. Viral lower respiratory tract infection in infants and young children. BMJ 327(7405), 36 (2003).
    • 8 Aguilar JC, Pérez-Breña MP, García ML, Cruz N, Erdman DD, Echevarría JE. Detection and identification of human parainfluenza viruses 1, 2, 3, and 4 in clinical samples of pediatric patients by multiplex reverse transcription-PCR. J. Clin. Microbiol. 38(3), 1191–1195 (2000).
    • 9 Driscoll AJ, Karron RA, Bhat N et al. Evaluation of fast-track diagnostics and TaqMan array card real-time PCR assays for the detection of respiratory pathogens. J. Microbial. Methods 107, 222–226 (2014).
    • 10 Tyrrell DA, Bynoe ML, Petersen KB, Sutton RN, Pereira MS. Inoculation of human volunteers with parainfluenza viruses types 1 and 3 (HA 2 and HA 1). BMJ 2(5157), 909–911 (1959).
    • 11 Fields BN, Knipe DM, Chanock RM et al. Fundamental Virology. Raven Press, New York, NY, USA (1991).
    • 12 Palmer SG, Devito I, Jenkins SG, Niewiesk S, Porotto M, Moscona A. Circulating clinical strains of human parainfluenza virus reveal viral entry requirements for in vivo infection. J. Virol. 88(22), 13495–13502 (2014).
    • 13 Pecchini R, Berezin EN, Souza MC et al. Parainfluenza virus as a cause of acute respiratory infection in hospitalized children. Braz. J. Infect. Dis. 19(4), 358–362 (2015).
    • 14 Fry AM, Curns AT, Harbour K, Hutwagner L, Holman RC, Anderson LJ. Seasonal trends of human parainfluenza viral infections: United States, 1990–2004. Clin. Infect. Dis. 43(8), 1016–1022 (2006). •• Shows that human parainfluenza viruses are the second most common cause of lower and upper respiratory tract infections in children younger than 5 years after respiratory syncytial virus.
    • 15 Hu A, Colella M, Zhao P et al. Development of a real-time RT-PCR assay for detection and quantitation of parainfluenza virus 3. J. Virol. Methods 130(1–2), 145–148 (2005).
    • 16 Villaran MV, Garcia J, Gomez J et al. Human parainfluenza virus in patients with influenza-like illness from Central and South America during 2006–2010. Influenza Other Respir. Viruses 8(2), 217–227 (2014).
    • 17 Lassauniere R, Kresfelder T, Venter M. A novel multiplex real-time RT-PCR assay with FRET hybridization probes for the detection and quantitation of 13 respiratory viruses. J. Virol. Methods 165(2), 254–260 (2010).
    • 18 Wolff B, Winchell JM, Diaz M. Real-time PCR for the detection of pathogens: US20150086987 A1 (2013). •• Used because of wide use of real-time PCR methods. It also highlights some of the critical points and limitations of these assays.
    • 19 Terlizzi ME, Massimiliano B, Francesca S et al. Quantitative RT real time PCR and indirect immunofluorescence for the detection of human parainfluenza virus 1, 2, 3. J. Virol. Methods 160(1–2), 172–177 (2009).
    • 20 Choudhary ML, Anand SP, Heydari M et al. Development of a multiplex one step RT-PCR that detects eighteen respiratory viruses in clinical specimens and comparison with real time RT-PCR. J. Virol. Methods 189(1), 15–19 (2013).
    • 21 Wang W, Ren P, Sheng J et al. Simultaneous detection of respiratory viruses in children with acute respiratory infection using two different multiplex reverse transcription-PCR assays. J. Virol. Methods 162(1–2), 40–45 (2009). •• Shows that real-time PCR has higher sensitivity over conventional methods and has the ability to be developed for the diagnosis of 14 viral pathogens of the respiratory tract.
    • 22 Sambrook J, Fritsch EF, Maniatis T. Molecular Cloning. Inglis J, Boyle A, Gann A (Eds). Cold Spring Harbor Laboratory Press, New York, NY, USA, 2 (1989).
    • 23 Dhanasekaran S, Mark Doherty T, Kenneth J. Comparison of different standards for real-time PCR-based absolute quantification. J. Immunol. Methods 354, 34–39 (2010).
    • 24 Piralla A, Daleno C, Pariani E et al. Virtual quantification of influenza A virus load by real-time RT-PCR. J. Clin. Virol. 56(1), 65–68 (2013). •• Provides proof of concept that virtual quantification tool would allow conversion of cycle threshold (CT) value in influenza A copy number in clinical samples.
    • 25 Pavšič J, Devonshire AS, Parkes H et al. Standardization of nucleic acid tests for clinical measurements of bacteria and viruses. J. Clin. Microbiol. 53(7), 2008–2014 (2015).
    • 26 Bailly B, Dirr L, El-Deeb IM, Altmeyer R, Guillon P, Von Itzstein M. A dual drug regimen synergistically blocks human parainfluenza virus infection. Sci. Rep. 6, 24138 (2016).
    • 27 Grist NR, Bell EJ, Follett E, Urquhart G. Diagnostic Methods in Clinical Virology. Blackwell Scientific Publications, Oxford, UK (1979).
    • 28 Yano T, Fukuta M, Maeda C et al. Epidemiological investigation and seroprevalence of human parainfluenza virus in Mie Prefecture in Japan during 2009–2013. Jpn J. Infect. Dis. 67(6), 506–508 (2014).
    • 29 Fé MMM, Monteiro AJ, Moura FEA. Parainfluenza virus infections in a tropical city: clinical and epidemiological aspects. Braz. J. Infect. Dis. 12(3), 192–197 (2008).
    • 30 Sultani M, Azad TM, Eshragian M et al. Multiplex SYBR green real-time PCR assay for detection of respiratory viruses. Jundishapur J. Microbiol. 8(8), e19041 (2015).